MINERVA NEUROSCIENCES, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.51 USD | 0.00% |
|
+6.81% | -59.19% |
| May. 01 | Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 27 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MINERVA NEUROSCIENCES, INC. | Bio Therapeutic Drugs | 0.00% | +6.81% | -59.19% | -63.09% | -95.53% | 17.55M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NERV Stock
- Charts Minerva Neurosciences, Inc.
- Comparison Chart